We facilitate clinical research on PFS, generate awareness of the condition, provide support to PFS patients and lobby for stricter regulations on finasteride.
Citing 19 Suicides and 170 Reports of Suicidal Ideation, British Regulator MHRA Announces Label Changes and Other Measures to Minimize Finasteride’s Risks #PostFinasterideSyndromeurli.info/1uR12
"I Couldn't Find Any Doctor Willing to Help Me… I'm Desperate," Jalan Lotfolahpour Wrote to the PFS Foundation at Age 20. Six Years Later, He Was Found Dead After Mixed-Drug Intoxication #PostFinasterideSyndromerb.gy/ry4c6l
Robb Dixon of SIDEfxHUB sits down with Dr. Ken Peters of William Beaumont School of Medicine, who organized the First World Congress on PSSD, PFS and PAS, to discuss the event—and next steps #PostFinasterideSyndromeyoutube.com/watch?v=wQfs--1y…
“I...would never take the medication,” said urologist Jonathan Clavell. “Because if I were one of the unlucky few who turns out to get [PFS], I know I’d regret it.” #PostFinasterideSyndromenytimes.com/2026/04/07/magaz…
Just realized that Kevin Ali, the CEO of Organon, which currently owns Propecia, was booted in October due to improper sales practices. Reuters: "Ali has agreed he will not be entitled to [his] severance." #PostFinasterideSyndromeshorturl.at/5o0fT
"The Post-Finasteride Syndrome Foundation...has recorded nearly 27,000 adverse reactions to the drug worldwide and 126 known suicides," reports Men's Health UK in We Need to Talk About Finasteride #PostFinasterideSyndromeshorturl.at/BpRVn
Rushing to Relieve Peripheral Neuropathy, WinSanTor Takes its Experimental WST-057 Drug to the State with America’s Most Permissive Right-to-Try Laws #PostFinasterideSyndromerb.gy/csijlt